Increased levels of TF have been reported in BAL fluid in patients with ARDS and patients at risk of ARDS while simultaneously being downregulated in plasma, presenting it as an exciting biomarker candidate in EBP [42]. This evidence concerns the gene TF and acute respiratory distress syndrome.